Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA Chief Counsel Bradshaw Brings DoJ Experience, Utah Political Ties

This article was originally published in The Gray Sheet

Executive Summary

Sheldon Bradshaw brings high-level government experience and strong political connections to the top legal position at FDA

You may also be interested in...



People In Brief

Top lawyer leaves FDA: FDA Chief Counsel Sheldon Bradshaw resigns from the agency Sept. 6 to join Hunton & Williams' food and drug practice, according to the law firm. A former Justice Department attorney, Bradshaw became the top lawyer at FDA in 2005, replacing Dan Troy (1"The Gray Sheet" April 11, 2005, p. 8). He will start at Hunton & Williams' Washington, D.C., office next month. Deputy Chief Counsel Jeffrey Senger will fill in as acting chief counsel until a permanent replacement is found, according to agency staffers...

People In Brief

Top lawyer leaves FDA: FDA Chief Counsel Sheldon Bradshaw resigns from the agency Sept. 6 to join Hunton & Williams' food and drug practice, according to the law firm. A former Justice Department attorney, Bradshaw became the top lawyer at FDA in 2005, replacing Dan Troy (1"The Gray Sheet" April 11, 2005, p. 8). He will start at Hunton & Williams' Washington, D.C., office next month. Deputy Chief Counsel Jeffrey Senger will fill in as acting chief counsel until a permanent replacement is found, according to agency staffers...

FDA Commish Pick Imminent? Crawford Finally May Shed Understudy Role

The White House seems to have selected FDA Acting Commissioner Lester Crawford, PhD/DVM, as its choice to fill the commissioner slot on a permanent basis

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

MT021905

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel